BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 30667332)

  • 21. Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine.
    Saxena S; Jena B; Gupta N; Das S; Sarmah D; Bhattacharya P; Nath T; Paul S; Fouda MM; Kalra M; Saba L; Pareek G; Suri JS
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial intelligence in cardiac radiology.
    van Assen M; Muscogiuri G; Caruso D; Lee SJ; Laghi A; De Cecco CN
    Radiol Med; 2020 Nov; 125(11):1186-1199. PubMed ID: 32946002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current role of machine learning and radiogenomics in precision neuro-oncology.
    Perillo T; de Giorgi M; Papace UM; Serino A; Cuocolo R; Manto A
    Explor Target Antitumor Ther; 2023; 4(4):545-555. PubMed ID: 37720347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artificial intelligence in the radiomic analysis of glioblastomas: A review, taxonomy, and perspective.
    Zhu M; Li S; Kuang Y; Hill VB; Heimberger AB; Zhai L; Zhai S
    Front Oncol; 2022; 12():924245. PubMed ID: 35982952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Academics as leaders in the cancer artificial intelligence revolution.
    Kochanny SE; Pearson AT
    Cancer; 2021 Mar; 127(5):664-671. PubMed ID: 33119903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial intelligence-based MRI radiomics and radiogenomics in glioma.
    Fan H; Luo Y; Gu F; Tian B; Xiong Y; Wu G; Nie X; Yu J; Tong J; Liao X
    Cancer Imaging; 2024 Mar; 24(1):36. PubMed ID: 38486342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics, Metabolic, and Molecular MRI for Brain Tumors.
    Kickingereder P; Andronesi OC
    Semin Neurol; 2018 Feb; 38(1):32-40. PubMed ID: 29548050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theranostics and artificial intelligence: new frontiers in personalized medicine.
    Belge Bilgin G; Bilgin C; Burkett BJ; Orme JJ; Childs DS; Thorpe MP; Halfdanarson TR; Johnson GB; Kendi AT; Sartor O
    Theranostics; 2024; 14(6):2367-2378. PubMed ID: 38646652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology.
    Huss R; Raffler J; Märkl B
    Cancer Rep (Hoboken); 2023 Jul; 6(7):e1796. PubMed ID: 36813293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the Artificial Intelligence Hype: What Lies Behind the Algorithms and What We Can Achieve.
    van Assen M; Banerjee I; De Cecco CN
    J Thorac Imaging; 2020 May; 35 Suppl 1():S3-S10. PubMed ID: 32073539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study.
    Vollmuth P; Foltyn M; Huang RY; Galldiks N; Petersen J; Isensee F; van den Bent MJ; Barkhof F; Park JE; Park YW; Ahn SS; Brugnara G; Meredig H; Jain R; Smits M; Pope WB; Maier-Hein K; Weller M; Wen PY; Wick W; Bendszus M
    Neuro Oncol; 2023 Mar; 25(3):533-543. PubMed ID: 35917833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are innovation and new technologies in precision medicine paving a new era in patients centric care?
    Seyhan AA; Carini C
    J Transl Med; 2019 Apr; 17(1):114. PubMed ID: 30953518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of artificial intelligence in brain tumour imaging.
    Chukwujindu E; Faiz H; Ai-Douri S; Faiz K; De Sequeira A
    Eur J Radiol; 2024 Jul; 176():111509. PubMed ID: 38788610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma.
    Luo J; Pan M; Mo K; Mao Y; Zou D
    Semin Cancer Biol; 2023 Jun; 91():110-123. PubMed ID: 36907387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward Personalized Medicine in Radiotherapy of Hepatocellular Carcinoma: Emerging Radiomic Biomarker Candidates of Response and Toxicity.
    De la Pinta C
    OMICS; 2021 Sep; 25(9):537-544. PubMed ID: 34448625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A narrative review on current imaging applications of artificial intelligence and radiomics in oncology: focus on the three most common cancers.
    Vicini S; Bortolotto C; Rengo M; Ballerini D; Bellini D; Carbone I; Preda L; Laghi A; Coppola F; Faggioni L
    Radiol Med; 2022 Aug; 127(8):819-836. PubMed ID: 35771379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image-based biomarkers for solid tumor quantification.
    Savadjiev P; Chong J; Dohan A; Agnus V; Forghani R; Reinhold C; Gallix B
    Eur Radiol; 2019 Oct; 29(10):5431-5440. PubMed ID: 30963275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiogenomics in prostate cancer evaluation.
    Thenault R; Gasmi A; Khene ZE; Bensalah K; Mathieu R
    Curr Opin Urol; 2021 Jul; 31(4):424-429. PubMed ID: 34009176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial intelligence-assisted selection and efficacy prediction of antineoplastic strategies for precision cancer therapy.
    Zhang Z; Wei X
    Semin Cancer Biol; 2023 May; 90():57-72. PubMed ID: 36796530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?
    Daisy PS; Anitha TS
    Med Oncol; 2021 Apr; 38(5):53. PubMed ID: 33811540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.